NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2003-12-09
Proposed Data Collections Submitted for Public Comment and Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2003-12-09
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 4981210. Send written
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2003-12-09
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2003-12-09
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2003-12-09
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
RULES: Skin protectant drug products (OTC)—; Astringent products; final monograph,
Published: 2003-12-09
The Food and Drug Administration (FDA) is amending the
regulation that established conditions under which overthecounter
(OTC) skin protectant drug products are generally recognized as safe
and effective and not misbranded as part of FDA's ongoing review of OTC
drug products. This amendment revises several of the indications for
OTC skin
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2003-12-09
The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Inspection by Accredited Persons
Program Under the Medical Device User Fee and Modernization Act of
2002'' has been approved by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995.
NOTICES: Oncological Drugs Advisory Committee; correction,
Published: 2003-12-09
The Food and Drug Administration (FDA) is announcing an
amendment to the notice of meeting of the Oncologic Drugs Advisory
Committee. This meeting was announced in the Federal Register of
November 18, 2003 (68 FR 6507665077). The amendment is being made to
reflect a change in the Location portion of the document. There are no
other changes.
NOTICES: Lin, Kuei-Fu (Tom),
Published: 2003-12-09
Notice is hereby given that the Office of Research Integrity
(ORI) and the Assistant Secretary for Health have taken final additional action in the following case:
KueiFu (Tom) Lin, D.V.M., Medical University of South Carolina
(MUSC): Based on the report of an investigation conducted by MUSC and
additional analysis conducted by ORI in its
NOTICES: Xu, Jianhua (James),
Published: 2003-12-09
Notice is hereby given that the Office of Research Integrity
(ORI) and the Acting Assistant Secretary for Health have taken final action in the following case:
Jianhua (James) Xu, M.S., University of Alberta: Based on the
University of Alberta (UA) Report, the respondent's admissions, and
additional analysis conducted by ORI in its oversight
NOTICES: Maternal and Child Health Federal Set-Aside Program—; Community-Based Abstinence Education Project,
Published: 2003-12-09
The Health Resources and Services Administration (HRSA)
announces that approximately $33 million in fiscal year (FY) 2004 funds
will be available for making competitive grants to provide abstinence education to adolescents, subject to the availability of
appropriations. There are no cost sharing, matching or cost
participation requirements of the
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2003-12-09
Under the provisions of section 3507(a)(1(D) of the Paperwork
Reduction Act of 1995, the National Cancer Institute, the National
Institutes of Health (NIH) has submitted to the Office of Management
and Budget (OMB) a request to review and approve the information
collection listed below. This proposed information collection was
previously published
NOTICES: Inventions, Government-owned; availability for licensing,
Published: 2003-12-09
The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
for companies
NOTICES: Inventions, Government-owned; availability for licensing,
Published: 2003-12-09
The invention listed below is owned by an agency of the U.S.
Government and is available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
for companies and
NOTICES: Inventions, Government-owned; availability for licensing,
Published: 2003-12-09
The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
for companies
NOTICES: National Institute of Neurological Disorders and Stroke,
Published: 2003-12-09
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the